A panel of cancer experts ruled Wednesday that Avastin - the world's best-selling cancer drug, developed by Genentech in South San Francisco - should no longer be used in breast cancer patients because of concerns the medicine didn't work as well in follow-up studies and may cause deadly bleeding.
Thursday, 30 June 2011
Friday, 27 May 2011
New breast cancer guidelines "unsafe": women
More than eight out of 10 women say new guidelines recommending against routine breast cancer screening of women under 50 are "unsafe," according to a small survey. But most of the women also grossly overestimate their risk of developing the disease, according to researchers from the University of Massachusetts Medical School.
Friday, 18 March 2011
Health minister reaches out to cancer patient refused Herceptin
They spoke woman to woman, but the talk between Ontario’s Health Minister and a breast-cancer patient could not have been more loaded: One has the power to change the other’s life.
Jill Anzarut, 35, has been pushing for a drug the provincial cancer agency will not provide – Herceptin – because her tumour at .5 cm was deemed too small.
Subscribe to:
Posts (Atom)